Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 134
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT05581979 | PSMA-PET Imaging of Salivary Gland Tumours and Other Rare Cancers | ||
| NCT04961632 | Dose-determining and Dose-confirmatory Study to Investigate the Optimal Dose of Tamoxifen in Breast Cancer Patients According to Genotype Status of TCF20 rs932376 | ||
| NCT00687648 | Cyclophosphamide, Methotrexate, and Prednisolone With or Without Aromatase Inhibitor Therapy in Treating Postmenopausal Women With Metastatic Breast Cancer | ||
| NCT02944708 | Trial Evaluating Maintenance Chemotherapy for Metastatic Nasopharyngeal Carcinoma | ||
| NCT04961489 | Impact of Measures Taken to Contain COVID-19 on Hospital Surgical Care Services and Clinical Outcomes | ||
| NCT00565708 | Aspirin for Dukes C and High Risk Dukes B Colorectal Cancers | ||
| NCT05286437 | Phase II Lenvatinib and Pembrolizumab in Endocrine Resistant Breast Cancer With Letrozole | ||
| NCT01029418 | AZD6244 and Sorafenib in Advanced Hepatocellular Carcinoma | ||
| NCT04025515 | Molecular Profiling Project | ||
| NCT03984578 | Window of Opportunity Study in Colorectal Cancer | ||
| NCT04118114 | Phase II Study of PRL3-ZUMAB in Advanced Solid Tumors | ||
| NCT05377034 | Multinational Phase II Trial to Compare Safety and Efficacy of SIRT (Y-90 Resin Microspheres) Followed by Atezolizumab Plus Bevacizumab, vs SIRT (SIRT-Y90) Followed by Placebo in Locally Advanced HCC Patients | ||
| NCT06044441 | Evaluation and Implementation Preparation of a Proactive Palliative Care Model (ENABLE-SG) | ||
| NCT04340024 | Discovery of Biomarkers for Intrinsic Radiation Sensitivity in Cancer Patients | ||
| NCT00263484 | Higher Frequency Zoledronic Acid in the Treatment of Multiple Myeloma | ||
| NCT01394315 | Diffuse Optical Tomography (DOT) for Monitoring Response to Neoadjuvant (Preoperative) Chemotherapy in Breast Cancer | ||
| NCT06160843 | Pembrolizumab and Olaparib Treatment for Relapsed or Refractory Peripheral T-Cell Lymphoma | ||
| NCT03233360 | Hepatocellular Carcinoma Registry in Asia: The INSIGHT Registry | ||
| NCT02368860 | OXIRI [Oxaliplatin (O), Xeloda (X) and Irinotecan (I)] in Pancreatic Adenocarcinoma | ||
| NCT02801734 | Enhancing Quality of Life in Patients (EQUIP) Intervention for Patients With Advanced Lung Cancer | ||
| NCT04912765 | Neoantigen Dendritic Cell Vaccine and Nivolumab in HCC and Liver Metastases From CRC | ||
| NCT06093061 | Tislelizumab and Metronomic Capecitabine as Maintenance in High-risk Locoregionally-advanced Nasopharyngeal Carcinoma | ||
| NCT04303403 | Study of Trametinib and Ruxolitinib in Colorectal Cancer and Pancreatic Adenocarcinoma | ||
| NCT03429972 | Regional Cryotherapy in Preventing Paclitaxel Induced Peripheral Neuropathy in Breast Cancer Patients | ||
| NCT05059340 | Study to Explore Post Surgical Outcomes Using Point-of-Gaze, Electromyography and Elastography of the SCM | ||
| NCT01228045 | A Study of Trastuzumab in Combination With TS-ONE & Cisplatin in First-line Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Gastric Cancer | ||
| NCT05929885 | Metronomic Capecitabine, Oxaliplatin and UGT1A1 Genotype-directed Irinotecan in Metastatic Pancreatic Cancer Patients | ||
| NCT05517135 | tReatment Individualisation By EBV stratificatiON in Nasopharyngeal Carcinoma: an Umbrella Platform Study (RIBBON-Umbrella) | ||
| NCT03430128 | Perioperative Immunonutrition for Patients Undergoing CRS and HIPEC | ||
| NCT02412267 | Study of Ofatumomab in Combination With ICE-chemotherapy in Patients With Diffuse Large B-cell Lymphoma (DLBCL) | ||
| NCT03325218 | Survival Expectations and Hope Among Cancer Patients at End-of-Life | ||
| NCT06244953 | Timely Interventions to Enable and Reach Patients With Heart Failure, and Their Caregivers With Palliative Care | ||
| NCT02931864 | Effects of an e-Home Based Symptom Management and Mindfulness Training Programme on QoL in Breast Cancer Survivors | ||
| NCT06418412 | A Pan-Asian Clinical Database of EGFR Exon 20 Insertion Mutated NSCLC | ||
| NCT01765686 | Comparing Harmonic Ultrasonic Scalpel to Small Jaw Bipolar Device in Thyroid Surgery | ||
| NCT05148572 | Prospective Cohort Study of Changes in Circulatory MicroRNA of Resected Hepatocellular Carcinoma | ||
| NCT02420067 | Screening for Endolymphatic Sac Tumours (ELSTs) in Von Hippel-Lindau (vHL) Patients | ||
| NCT04014309 | Accessible Cancer Care to Enable Support for Survivors Programme | ||
| NCT06294808 | Predicting Survival After Surgical Resection for the Entire Spectrum of Anatomically Resectable HCC | ||
| NCT02736305 | Use of Regorafenib in Recurrent Epithelial Ovarian Cancer | ||
| NCT05773092 | A Phase 2 Study of Osimertinib and S-1 in Treatment Resistant EGFR Mutant NSCLC | ||
| NCT03330509 | Effectiveness of the Supportive and Palliative Care Review Kit (SPARK) for Cancer Patients in the Acute Hospital | ||
| NCT02808091 | Bortezomib With Combination of Gemcitabine, Ifosfamide and Oxaliplatin in Untreated NK/T Cell Lymphoma | ||
| NCT03097939 | Phase 2 Trial of Ipilimumab and Nivolumab in Nasopharyngeal Carcinoma | ||
| NCT00702481 | Study of Nimotuzumab and Cisplatin/Radiotherapy for Locally Advanced Head and Neck Squamous Cell Cancer | ||
| NCT04448522 | Reduced vs Conventional Dosage Intensity-modulated Radiotherapy for Chemotherapy-sensitive Stage II-III Nasopharyngeal Carcinoma | ||
| NCT01865838 | A Study Into the Effect of Seprafilm in Open Total Thyroidectomy | ||
| NCT04632173 | Head and Neck cancERs International cOviD-19 collabOraTion | ||
| NCT00589186 | Vaccine Therapy and Celecoxib in Treating Patients With Metastatic Nasopharyngeal Cancer | ||
| NCT02143388 | Concurrent Cisplatin Chemoradiation With or Without Capecitabine as Adjuvant Chemotherapy in Local Advanced High Risk Nasopharyngeal Carcinoma: Randomized Control Clinical Trial |
